CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…
Read MoreObesity
FDA Approves Wegovy for Cardiovascular Risk Reduction
The injection becomes the first weight loss medication to address life-threatening cardiovascular events. The Food and Drug Administration has expanded the approved use of Wegovy (semaglutide) injection, making…
Read MoreUSDA Launches Nutrition Hub
Pilot program intended to counter diet-related diseases. The U.S. Department of Agriculture (USDA) has launched a pilot nutrition hub, in collaboration with Southern University, to provide science-based nutrition…
Read More